About

Publication thumbnail: Opportunities and limitations of B bell depletion approaches in SLE

Opportunities and limitations of B bell depletion approaches in SLE

Publication thumbnail: Efficacy and safety of obinutuzumab in active lupus nephritis

Efficacy and safety of obinutuzumab in active lupus nephritis

Publication thumbnail: Belimumab versus telitacicept in sequential treatment after rituximab for refractory lupus nephritis:  A real-world multicentre study

Belimumab versus telitacicept in sequential treatment after rituximab for refractory lupus nephritis: A real-world multicentre study

Publication thumbnail: Cenerimod, a sphingosine-1-phosphate receptor modulator, versus placebo in patients with moderate-to-severe systemic lupus erythematosus (CARE): an international, double-blind, randomised, placebo-controlled, phase 2 trial

Cenerimod, a sphingosine-1-phosphate receptor modulator, versus placebo in patients with moderate-to-severe systemic lupus erythematosus (CARE): an international, double-blind, randomised, placebo-controlled, phase 2 trial

Steering Committee